Mangalam Drugs faces financial pressure, defaulting on over Rs. 15.57 Cr in bank loans (BoM, BoB) for >30 days, indicating liquidity issues. Management is arranging payments to resolve the overdue amounts, aiming to mitigate further impact.
Mangalam Drugs and Organics reported the resignation of its Secretarial Auditor, M/s. Ragini Chokshi & Co. The auditor cited pre-occupancy with professional commitments as the reason for stepping down.